Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.Helsinn is an important player in Cancer Supportive CareHelsinn in-licenses early-to-late stage new chemical entities from small and big pharma companies, completes their development through the performance of preclinical and clinical studies and of chemistry, manufacturing and control